328 related articles for article (PubMed ID: 2410549)
1. Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies.
Gould EA; Buckley A; Cammack N; Barrett AD; Clegg JC; Ishak R; Varma MG
J Gen Virol; 1985 Jul; 66 ( Pt 7)():1369-82. PubMed ID: 2410549
[TBL] [Abstract][Full Text] [Related]
2. Identification of monoclonal antibodies that distinguish between 17D-204 and other strains of yellow fever virus.
Barrett AD; Mathews JH; Miller BR; Medlen AR; Ledger TN; Roehrig JT
J Gen Virol; 1990 Jan; 71 ( Pt 1)():13-8. PubMed ID: 1689367
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein.
Schlesinger JJ; Brandriss MW; Monath TP
Virology; 1983 Feb; 125(1):8-17. PubMed ID: 6187129
[TBL] [Abstract][Full Text] [Related]
4. Neutralization of yellow fever virus studied using monoclonal and polyclonal antibodies.
Buckley A; Gould EA
J Gen Virol; 1985 Dec; 66 ( Pt 12)():2523-31. PubMed ID: 2999305
[TBL] [Abstract][Full Text] [Related]
5. Use of a monoclonal antibody specific for wild-type yellow fever virus to identify a wild-type antigenic variant in 17D vaccine pools.
Gould EA; Buckley A; Cane PA; Higgs S; Cammack N
J Gen Virol; 1989 Jul; 70 ( Pt 7)():1889-94. PubMed ID: 2472467
[TBL] [Abstract][Full Text] [Related]
6. Yellow fever monoclonal antibodies: type-specific and cross-reactive determinants identified by immunofluorescence.
Monath TP; Schlesinger JJ; Brandriss MW; Cropp CB; Prange WC
Am J Trop Med Hyg; 1984 Jul; 33(4):695-8. PubMed ID: 6206738
[TBL] [Abstract][Full Text] [Related]
7. Analysis of 17D yellow fever virus envelope protein epitopes using monoclonal antibodies.
Schlesinger JJ; Walsh EE; Brandriss MW
J Gen Virol; 1984 Oct; 65 ( Pt 10)():1637-44. PubMed ID: 6208313
[TBL] [Abstract][Full Text] [Related]
8. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48.
Schlesinger JJ; Brandriss MW; Walsh EE
J Immunol; 1985 Oct; 135(4):2805-9. PubMed ID: 4031501
[TBL] [Abstract][Full Text] [Related]
9. Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses.
Brandriss MW; Schlesinger JJ; Walsh EE; Briselli M
J Gen Virol; 1986 Feb; 67 ( Pt 2)():229-34. PubMed ID: 3944585
[TBL] [Abstract][Full Text] [Related]
10. Examination of the envelope glycoprotein of yellow fever vaccine viruses with monoclonal antibodies.
Barrett AD; Pryde A; Medlen AR; Ledger TN; Whitby JE; Gibson CA; DeSilva M; Groves DJ; Langley DJ; Minor PD
Vaccine; 1989 Aug; 7(4):333-6. PubMed ID: 2479185
[TBL] [Abstract][Full Text] [Related]
11. Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice.
Gould EA; Buckley A; Barrett AD; Cammack N
J Gen Virol; 1986 Mar; 67 ( Pt 3)():591-5. PubMed ID: 3950582
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of a purified fragment of 17D yellow fever envelope protein.
Brandriss MW; Schlesinger JJ; Walsh EE
J Infect Dis; 1990 Jun; 161(6):1134-9. PubMed ID: 1693159
[TBL] [Abstract][Full Text] [Related]
13. Location of a neutralization determinant in the E protein of yellow fever virus (17D vaccine strain).
Lobigs M; Dalgarno L; Schlesinger JJ; Weir RC
Virology; 1987 Dec; 161(2):474-8. PubMed ID: 2446422
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies identify the NS5 yellow fever virus non-structural protein in the nuclei of infected cells.
Buckley A; Gaidamovich S; Turchinskaya A; Gould EA
J Gen Virol; 1992 May; 73 ( Pt 5)():1125-30. PubMed ID: 1534119
[TBL] [Abstract][Full Text] [Related]
15. Antigenic analysis of yellow fever virus glycoproteins: use of monoclonal antibodies in enzyme-linked immunosorbent assays.
Cammack N; Gould EA
J Virol Methods; 1986 May; 13(2):135-42. PubMed ID: 3016014
[TBL] [Abstract][Full Text] [Related]
16. [Monoclonal antibodies to flavivirus antigens induced by a vaccinal strain of yellow fever].
Gaĭdamovich SIa; Mel'nikova EE; Mikheeva TG; Shutkova TM; Sveshnikova NA
Vopr Virusol; 1988; 33(4):461-5. PubMed ID: 2848367
[TBL] [Abstract][Full Text] [Related]
17. 17D yellow fever vaccine virus envelope protein expressed by recombinant baculovirus is antigenically indistinguishable from authentic viral protein.
Shiu SY; Morikawa S; Buckley A; Higgs S; Karunakarannair V; Blachere C; Gould EA
J Gen Virol; 1991 Jun; 72 ( Pt 6)():1451-4. PubMed ID: 1710651
[TBL] [Abstract][Full Text] [Related]
18. Variation in the biological function of envelope protein epitopes of yellow fever vaccine viruses detected with monoclonal antibodies.
Ledger TN; Sil BK; Wills MR; Lewis G; Kinney RM; Jennings AD; Stephenson JR; Barrett AD
Biologicals; 1992 Jun; 20(2):117-28. PubMed ID: 1389107
[TBL] [Abstract][Full Text] [Related]
19. Identification of envelope protein epitopes that are important in the attenuation process of wild-type yellow fever virus.
Sil BK; Dunster LM; Ledger TN; Wills MR; Minor PD; Barrett AD
J Virol; 1992 Jul; 66(7):4265-70. PubMed ID: 1376368
[TBL] [Abstract][Full Text] [Related]
20. Neutralizing F(ab')2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis.
Schlesinger JJ; Chapman S
J Gen Virol; 1995 Jan; 76 ( Pt 1)():217-20. PubMed ID: 7844536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
